Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R White

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
The Journal of Allergy and Clinical Immunology|April 29, 2022
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthmaJanet K Jackman, Amy Stockwell, David F Choy, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2014
A genome-wide survey of CD4(+) lymphocyte regulatory genetic variants identifies novel asthma genesSunita Sharma, Xiaobo Zhou, Derek M Thibault, et al.
The Lancet. Respiratory Medicine|May 8, 2020
Expression quantitative trait locus fine mapping of the 17q12-21 asthma locus in African American children: a genetic association and gene expression studyCarole Ober, Chris G McKennan, Kevin M Magnaye, et al.
JAMA|May 20, 2014
Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trialMario Castro, Tonya S King, Susan J Kunselman, et al.
The Lancet. Respiratory Medicine|February 4, 2021
Geography, generalisability, and susceptibility in clinical trialsJane E Clougherty, Ellen J Kinnee, Juan Carlos Cardet, et al.
Journal of Biopharmaceutical Statistics|September 17, 2020
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerationsAnastasia Ivanova, Elliot Israel, Lisa M LaVange, et al.
The Lancet. Child & Adolescent Health|November 11, 2021
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthmaVictor E Ortega, Michelle Daya, Stanley J Szefler, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2026
PrecISE- A Biomarker Stratified Adaptive Trial of 5 Interventions in Severe Asthma: Final Protocol and the Baseline CohortLoren C Denlinger, Elliot Israel, Wendy C Moore, et al.
The Journal of Allergy and Clinical Immunology|March 5, 2021
PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainmentElliot Israel, Loren C Denlinger, Leonard B Bacharier, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2021
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventionsSteve N Georas, Rosalind J Wright, Anastasia Ivanova, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
The Journal of Allergy and Clinical Immunology|April 29, 2022
Genome-wide association study identifies kallikrein 5 in type 2 inflammation-low asthmaJanet K Jackman, Amy Stockwell, David F Choy, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2014
A genome-wide survey of CD4(+) lymphocyte regulatory genetic variants identifies novel asthma genesSunita Sharma, Xiaobo Zhou, Derek M Thibault, et al.
The Lancet. Respiratory Medicine|May 8, 2020
Expression quantitative trait locus fine mapping of the 17q12-21 asthma locus in African American children: a genetic association and gene expression studyCarole Ober, Chris G McKennan, Kevin M Magnaye, et al.
JAMA|May 20, 2014
Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trialMario Castro, Tonya S King, Susan J Kunselman, et al.
The Lancet. Respiratory Medicine|February 4, 2021
Geography, generalisability, and susceptibility in clinical trialsJane E Clougherty, Ellen J Kinnee, Juan Carlos Cardet, et al.
Journal of Biopharmaceutical Statistics|September 17, 2020
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerationsAnastasia Ivanova, Elliot Israel, Lisa M LaVange, et al.
The Lancet. Child & Adolescent Health|November 11, 2021
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthmaVictor E Ortega, Michelle Daya, Stanley J Szefler, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2026
PrecISE- A Biomarker Stratified Adaptive Trial of 5 Interventions in Severe Asthma: Final Protocol and the Baseline CohortLoren C Denlinger, Elliot Israel, Wendy C Moore, et al.
The Journal of Allergy and Clinical Immunology|March 5, 2021
PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainmentElliot Israel, Loren C Denlinger, Leonard B Bacharier, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2021
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventionsSteve N Georas, Rosalind J Wright, Anastasia Ivanova, et al.
Pageof 11